These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 19383091)
1. Different binding modes of tropeines mediating inhibition and potentiation of alpha1 glycine receptors. Maksay G; Laube B; Schemm R; Grudzinska J; Drwal M; Betz H J Neurochem; 2009 Jun; 109(6):1725-32. PubMed ID: 19383091 [TBL] [Abstract][Full Text] [Related]
2. Binding-site mutations in the alpha1 subunit of the inhibitory glycine receptor convert the inhibitory metal ion Cu2+ into a positive modulator. Schumann T; Grudzinska J; Kuzmin D; Betz H; Laube B Neuropharmacology; 2009 Jan; 56(1):310-7. PubMed ID: 18793654 [TBL] [Abstract][Full Text] [Related]
3. Probing the pharmacological properties of distinct subunit interfaces within heteromeric glycine receptors reveals a functional ββ agonist-binding site. Dutertre S; Drwal M; Laube B; Betz H J Neurochem; 2012 Jul; 122(1):38-47. PubMed ID: 22486198 [TBL] [Abstract][Full Text] [Related]
4. Tropisetron modulation of the glycine receptor: femtomolar potentiation and a molecular determinant of inhibition. Yang Z; Ney A; Cromer BA; Ng HL; Parker MW; Lynch JW J Neurochem; 2007 Feb; 100(3):758-69. PubMed ID: 17181559 [TBL] [Abstract][Full Text] [Related]
5. Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2. Lee BH; Lee JH; Yoon IS; Lee JH; Choi SH; Pyo MK; Jeong SM; Choi WS; Shin TJ; Lee SM; Rhim H; Park YS; Han YS; Paik HD; Cho SG; Kim CH; Lim YH; Nah SY Brain Res; 2007 Aug; 1161():1-10. PubMed ID: 17603028 [TBL] [Abstract][Full Text] [Related]
6. Subunit-specific potentiation of recombinant glycine receptors by NV-31, a bilobalide-derived compound. Lynch JW; Chen X Neurosci Lett; 2008 Apr; 435(2):147-51. PubMed ID: 18329806 [TBL] [Abstract][Full Text] [Related]
7. Multiple sites of ethanol action in alpha1 and alpha2 glycine receptors suggested by sensitivity to pressure antagonism. Davies DL; Crawford DK; Trudell JR; Mihic SJ; Alkana RL J Neurochem; 2004 Jun; 89(5):1175-85. PubMed ID: 15147510 [TBL] [Abstract][Full Text] [Related]
8. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling. Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381 [TBL] [Abstract][Full Text] [Related]
9. Identification of residues critical for Cu2+-mediated inhibition of glycine alpha1 receptors. Chen Z; Dillon GH; Huang R Neuropharmacology; 2006 Sep; 51(4):701-8. PubMed ID: 16842826 [TBL] [Abstract][Full Text] [Related]
10. The beta subunit increases the ginkgolide B sensitivity of inhibitory glycine receptors. Kondratskaya EL; Betz H; Krishtal OA; Laube B Neuropharmacology; 2005 Nov; 49(6):945-51. PubMed ID: 16125206 [TBL] [Abstract][Full Text] [Related]
11. Effects of a mutation in the TM2-TM3 linker region of the glycine receptor alpha1 subunit on gating and allosteric modulation. Dupre ML; Broyles JM; Mihic SJ Brain Res; 2007 Jun; 1152():1-9. PubMed ID: 17434460 [TBL] [Abstract][Full Text] [Related]